Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SequelaeCov: a Prospective Study on Lung Damage Caused by SARS-CoV-2 Pneumonia

NCT04435327 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT04435327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SequelaeCov: a Prospective Study on Lung Damage Caused by SARS-CoV-2 Pneumonia
Lead sponsor
University of Milano Bicocca
Phase
Observational
Overall status
Completed
Start date
October 5, 2020
Completion date
March 18, 2022
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barotrauma, bronchiectasis adult, covid, emphysema, interstitial lung disease, pneumonia, viral